Robert NEGRIN, M.D.
Dr. Negrin is Professor of Medicine in the Division of Blood and Marrow
Transplantation at Stanford University. He also holds the positions of
Medical Director of the Clinical Bone Marrow Transplantation Laboratory and
Division Chief of the Bone Marrow Transplant Program at Stanford University.
He trained in both medicine and hematology at Stanford University and joined
the faculty in 1990. His research work has focused on cellular immunology,
in particular developing a more fundamental understanding of complex
biological reactions such as graft versus host and graft versus tumor
reactions in animal models and in the clinic. Dr. Negrin was recently
President of the American Society of Blood and Marrow Transplantation and is
the recipient of many prestigious honors including the 2004 Distinguished
Clinical Scientist Award from the Doris Duke Foundation. Dr. Negrin
received his undergraduate degree from the University of California at
Berkeley and MD from Harvard University. He has authored over 125 original
papers and 35 book chapters.


Hideto KANASHIMA, MD, Ph.D.

Dr. Kanashima is an independent biotechnology industry consultant and co-founder of Bio-Xcelerator, Inc., a biotechnology consulting and incubator business he started in 1999. He served as director in the field of life sciences at the Silicon Valley office of the University of Tokyo from 2000 to 2006. Previously, with his mentors and colleagues, Dr. Kanashima participated in the establishment of Systemix, Inc. in Silicon Valley, following two years of research at Stanford University School of Medicine. He played a leading role in the development of gene therapies and cell transplant therapies as director of the Systemix research division. Dr. Kanashima received his MD from the Nagoya University School of Medicine and his Ph.D. in pathology and immunology at the Nagoya University Graduate School of Medicine. He is the author of a number of papers in international medical journals and has applied for many patents.